Sprott Inc’s Gain Therapeutics GANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,000	Closed	-$26.7K	–	205
2025 Q1	$26.7K	Hold	14,000	–	–	﹤0.01%	182
2024 Q4	$30.2K	Buy	+14,000	New	+$30.2K	﹤0.01%	174